+ADw-html xmlns:v+AD0AIg-urn:schemas-microsoft-com:vml+ACI- xmlns:o+AD0AIg-urn:schemas-microsoft-com:office:office+ACI- xmlns:w+AD0AIg-urn:schemas-microsoft-com:office:word+ACI- xmlns:st1+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- xmlns+AD0AIg-http://www.w3.org/TR/REC-html40+ACIAPg- +ADw-head+AD4- +ADw-meta http-equiv+AD0-Content-Type content+AD0AIg-text/html+ADs- charset+AD0-utf-7+ACIAPg- +ADw-meta name+AD0-ProgId content+AD0-Word.Document+AD4- +ADw-meta name+AD0-Generator content+AD0AIg-Microsoft Word 11+ACIAPg- +ADw-meta name+AD0-Originator content+AD0AIg-Microsoft Word 11+ACIAPg- +ADw-link rel+AD0-File-List href+AD0AIg-als24283+AF8-files/filelist.xml+ACIAPg- +ADw-link rel+AD0-Edit-Time-Data href+AD0AIg-als24283+AF8-files/editdata.mso+ACIAPg- +ADwAIQ---+AFs-if +ACE-mso+AF0APg- +ADw-style+AD4- v+AFw-:+ACo- +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- o+AFw-:+ACo- +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- w+AFw-:+ACo- +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- .shape +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- +ADw-/style+AD4- +ADwAIQBb-endif+AF0---+AD4- +ADw-title+AD4-Anti-survivin antibodies from RDI Division of Fitzgerald Industries Intl+ADw-/title+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-country-region+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-PostalCode+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-Street+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-address+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-State+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-City+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-place+ACI-/+AD4- +ADwAIQ---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-o:DocumentProperties+AD4- +ADw-o:Author+AD4-Martha Rozynski+ADw-/o:Author+AD4- +ADw-o:LastAuthor+AD4-Martha Rozynski+ADw-/o:LastAuthor+AD4- +ADw-o:Revision+AD4-2+ADw-/o:Revision+AD4- +ADw-o:TotalTime+AD4-0+ADw-/o:TotalTime+AD4- +ADw-o:Created+AD4-2008-05-16T21:12:00Z+ADw-/o:Created+AD4- +ADw-o:LastSaved+AD4-2008-05-16T21:12:00Z+ADw-/o:LastSaved+AD4- +ADw-o:Pages+AD4-1+ADw-/o:Pages+AD4- +ADw-o:Words+AD4-373+ADw-/o:Words+AD4- +ADw-o:Characters+AD4-2128+ADw-/o:Characters+AD4- +ADw-o:Company+AD4-Trinity Biotech USA+ADw-/o:Company+AD4- +ADw-o:Lines+AD4-17+ADw-/o:Lines+AD4- +ADw-o:Paragraphs+AD4-4+ADw-/o:Paragraphs+AD4- +ADw-o:CharactersWithSpaces+AD4-2497+ADw-/o:CharactersWithSpaces+AD4- +ADw-o:Version+AD4-11.9999+ADw-/o:Version+AD4- +ADw-/o:DocumentProperties+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-w:WordDocument+AD4- +ADw-w:GrammarState+AD4-Clean+ADw-/w:GrammarState+AD4- +ADw-w:ValidateAgainstSchemas/+AD4- +ADw-w:SaveIfXMLInvalid+AD4-false+ADw-/w:SaveIfXMLInvalid+AD4- +ADw-w:IgnoreMixedContent+AD4-false+ADw-/w:IgnoreMixedContent+AD4- +ADw-w:AlwaysShowPlaceholderText+AD4-false+ADw-/w:AlwaysShowPlaceholderText+AD4- +ADw-w:BrowserLevel+AD4-MicrosoftInternetExplorer4+ADw-/w:BrowserLevel+AD4- +ADw-/w:WordDocument+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-w:LatentStyles DefLockedState+AD0AIg-false+ACI- LatentStyleCount+AD0AIg-156+ACIAPg- +ADw-/w:LatentStyles+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if +ACE-mso+AF0APgA8-object classid+AD0AIg-clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D+ACI- id+AD0-ieooui+AD4APA-/object+AD4- +ADw-style+AD4- st1+AFw-:+ACoAew-behavior:url(+ACM-ieooui) +AH0- +ADw-/style+AD4- +ADwAIQBb-endif+AF0---+AD4- +ADw-style+AD4- +ADwAIQ--- /+ACo- Style Definitions +ACo-/ p.MsoNormal, li.MsoNormal, div.MsoNormal +AHs-mso-style-parent:+ACIAIgA7- margin:0in+ADs- margin-bottom:.0001pt+ADs- mso-pagination:widow-orphan+ADs- font-size:12.0pt+ADs- font-family:+ACI-Times New Roman+ACIAOw- mso-fareast-font-family:+ACI-Times New Roman+ACIAOwB9- p +AHs-font-size:12.0pt+ADs- font-family:+ACI-Times New Roman+ACIAOw- mso-fareast-font-family:+ACI-Times New Roman+ACIAOwB9- span.GramE +AHs-mso-style-name:+ACIAIgA7- mso-gram-e:yes+ADsAfQ- +AEA-page Section1 +AHs-size:8.5in 11.0in+ADs- margin:1.0in 1.25in 1.0in 1.25in+ADs- mso-header-margin:.5in+ADs- mso-footer-margin:.5in+ADs- mso-paper-source:0+ADsAfQ- div.Section1 +AHs-page:Section1+ADsAfQ- --+AD4- +ADw-/style+AD4- +ADwAIQ---+AFs-if gte mso 10+AF0APg- +ADw-style+AD4- /+ACo- Style Definitions +ACo-/ table.MsoNormalTable +AHs-mso-style-name:+ACI-Table Normal+ACIAOw- mso-tstyle-rowband-size:0+ADs- mso-tstyle-colband-size:0+ADs- mso-style-noshow:yes+ADs- mso-style-parent:+ACIAIgA7- mso-padding-alt:0in 5.4pt 0in 5.4pt+ADs- mso-para-margin:0in+ADs- mso-para-margin-bottom:.0001pt+ADs- mso-pagination:widow-orphan+ADs- font-size:10.0pt+ADs- font-family:+ACI-Times New Roman+ACIAOw- mso-ansi-language:+ACM-0400+ADs- mso-fareast-language:+ACM-0400+ADs- mso-bidi-language:+ACM-0400+ADsAfQ- +ADw-/style+AD4- +ADwAIQBb-endif+AF0---+AD4- +ADw-meta name+AD0-description content+AD0AIg-Anti-Survivin antibodies from RDI Divison of Fitzgerald Industries Intl.+ACIAPg- +ADw-meta name+AD0-keywords content+AD0AIg-rdi-als24283,survivin,,+ACIAPg- +ADwAIQ---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-o:shapedefaults v:ext+AD0AIg-edit+ACI- spidmax+AD0AIg-2050+ACI-/+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-o:shapelayout v:ext+AD0AIg-edit+ACIAPg- +ADw-o:idmap v:ext+AD0AIg-edit+ACI- data+AD0AIg-1+ACI-/+AD4- +ADw-/o:shapelayout+AD4APA-/xml+AD4APAAhAFs-endif+AF0---+AD4- +ADw-/head+AD4- +ADw-body lang+AD0-EN-US link+AD0-blue vlink+AD0-blue style+AD0-'tab-interval:.5in'+AD4- +ADw-div class+AD0-Section1+AD4- +ADw-p+AD4APA-span class+AD0-GramE+AD4-rev+ADw-/span+AD4-: +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- 5/16/2008+ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/index.htm+ACIAPg-HOME+ADw-/a+AD4- +ACY-nbsp+ADs- (index page) +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/absort.htm+ACIAPg-Return +ADw-/a+AD4AJg-nbsp+ADs- (alphabetical antibody page) +ADw-/p+AD4- +ADw-p align+AD0-center style+AD0-'text-align:center'+AD4APA-br+AD4- +ADw-b+AD4AJg-nbsp+ADs- ANTIBODIES+ADw-/b+AD4- +ACY-nbsp+ADs- +ADw-/p+AD4- +ADw-p align+AD0-center style+AD0-'text-align:center'+AD4-(+ADw-span class+AD0-GramE+AD4-anti-Human+ADw-/span+AD4- and others as indicated) +ADw-/p+AD4- +ADw-p+AD4-RDI Division of Fitzgerald Industries +ADw-span class+AD0-GramE+AD4-Intl +ACY-nbsp+ADs-offers+ADw-/span+AD4- a wide line of +ACY-nbsp+ADs-antibodies. Since no one antibody works best for all applications (neutralization, blotting, ELISA, etc), we offer many different types of antibodies to help solve this problem. Please inquire for other applications or types of antibodies not listed below. +ADw-/p+AD4- +ADw-div class+AD0-MsoNormal align+AD0-center style+AD0-'text-align:center'+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- align+AD0-center+AD4- +ADw-/div+AD4- +ADw-p class+AD0-MsoNormal+AD4APA-b+AD4-Anti-Survivin Polyclonal Antibody+ADw-/b+AD4- +ADw-/p+AD4- +ADw-p+AD4-Catalog Number: RDI-ALS24283 +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADsAJA-346.50/100ug +ADw-/p+AD4- +ADw-p+AD4AJg-nbsp+ADs- +ACY-nbsp+ADsAJg-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs-RDI-ALS24283X +ACY-nbsp+ADs- +ACQ-1875.00/1mg +ADw-/p+AD4- +ADw-p+AD4APA-st1:place w:st+AD0AIg-on+ACIAPg-Lot+ADw-/st1:place+AD4- Number: +ADw-/p+AD4- +ADw-p+AD4-Quantity: 100ug in 100ul (1 mg/ml) in PBS containing 0.02+ACU- sodium azide. +ADw-/p+AD4- +ADw-p+AD4-Description: Survivin is a human gene encoding a structurally unique IAP apoptosis inhibitor. Present during fetal development, survivin is undetectable in terminally differentiated adult tissues. However, survivin becomes prominently expressed in transformed cell lines and in all the most common human cancers of lung, colon, pancreas, prostate and breast, in vivo. Survivin is also found in high-grade non-Hodgkin's lymphomas. These data suggest that apoptosis inhibition may be a general feature of neoplasia and identify survivin as a potential new target for apoptosis-based therapy in cancer and lymphoma. +ADw-/p+AD4- +ADw-p+AD4-Host Species: Rabbit +ADw-/p+AD4- +ADw-p+AD4-Specificity: Reacts with residues 125-142 EETAKKVRRAIEQLAAMD of the human Survivin protein. Cross reacts with mouse and rat +ADw-span class+AD0-GramE+AD4-Survivin+ADw-/span+AD4- (88+ACU- sequence identity). +ADw-/p+AD4- +ADw-p+AD4-Applications: Western blot - Use at 1:500 to 1:1,000 +ADw-span class+AD0-GramE+AD4-dilution+ADw-/span+AD4-. However, the investigator should determine the optimal dilution for a specific +ACY-nbsp+ADs- application such as immunohistochemistry. +ADw-/p+AD4- +ADw-p+AD4-Format: Affinity purified IgG +ADw-/p+AD4- +ADw-p+AD4-Storage: Maintain at 8+ALA-C for 3 months or at -20+ALA-C for longer periods. +ADw-span class+AD0-GramE+AD4-Stable for 1 year.+ADw-/span+AD4- Avoid repeated freeze-thaw cycles. +ADw-/p+AD4- +ADw-p+AD4-Reference: Ambrosini G., Adida C., and +ADw-st1:place w:st+AD0AIg-on+ACIAPgA8-st1:City w:st+AD0AIg-on+ACIAPg-Altieri+ADw-/st1:City+AD4- +ADw-st1:State w:st+AD0AIg-on+ACIAPg-D.C.+ADw-/st1:State+AD4APA-/st1:place+AD4- Nat Med 1997 Aug+ADw-span class+AD0-GramE+AD4AOw-3+ADw-/span+AD4-(8):917-21. +ADw-/p+AD4- +ADw-p+AD4-For in vitro research use only-not for use in or on humans or animals +ADw-/p+AD4- +ADw-div class+AD0-MsoNormal align+AD0-center style+AD0-'text-align:center'+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- align+AD0-center+AD4- +ADw-/div+AD4- +ADw-p+AD4-RDI Division of Fitzgerald Industries Intl +ADw-/p+AD4- +ADw-p+AD4APA-st1:Street w:st+AD0AIg-on+ACIAPgA8-st1:address w:st+AD0AIg-on+ACIAPg-34 Junction Square+ADw-/st1:address+AD4APA-/st1:Street+AD4- Drive +ADw-/p+AD4- +ADw-p+AD4APA-st1:place w:st+AD0AIg-on+ACIAPgA8-st1:City w:st+AD0AIg-on+ACIAPg-Concord+ADw-/st1:City+AD4- +ADw-st1:State w:st+AD0AIg-on+ACIAPg-MA+ADw-/st1:State+AD4- +ADw-st1:PostalCode w:st+AD0AIg-on+ACIAPg-01742+ADw-/st1:PostalCode+AD4APA-/st1:place+AD4--3049 +ADw-/p+AD4- +ADw-p+AD4APA-st1:country-region w:st+AD0AIg-on+ACIAPgA8-st1:place w:st+AD0AIg-on+ACIAPg-USA+ADw-/st1:place+AD4APA-/st1:country-region+AD4- +ADw-/p+AD4- +ADw-p+AD4APA-span class+AD0-GramE+AD4-phone+ADw-/span+AD4- (978) 371-6446 or (800) 370-2222 +ADw-/p+AD4- +ADw-p+AD4APA-span class+AD0-GramE+AD4-fax+ADw-/span+AD4- +ACY-nbsp+ADs- +ACY-nbsp+ADs- (978) 371-2266 +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-mailto:antibodies+AEA-fitzgerald-fii.com+ACIAPg-EMAIL:antibodies+AEA-fitzgerald-fii.com+ADw-/a+AD4- +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/absort.htm+ACIAPg-Return +ADw-/a+AD4AJg-nbsp+ADs- (alphabetical antibody page) +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/terms.htm+ACIAPg-Ordering +ADw-/a+AD4-terms +ADw-/p+AD4- +ADw-/div+AD4- +ADw-/body+AD4- +ADw-/html+AD4-